Am I an idiot?

Currently in ER, and I have a goal of bumping into investment banking. I plan on working two years of IB then going and completing a PhD in molecular bio. After the phd, I wanna bump into biotech hedge funds or even start a biotech company. Am I just absolutely stupid to do this? Should I just stay in ER and/or IB and call it good? I am worried by doing this I am risking my career and may be pigeon holed out the industry. Would love advice from you all.

Cheers! 

10 Comments
 

I think the opportunity cost is too high to do a PhD, especially when you are in FO...

I wanted to do a PhD in economics, but it's much more challenging and would earn me like 20% of the money for 5-7 years... Decided retiring in my 30's would be better than earning a PhD.

 

My group works with a lot of biopharma. Space is so cool, definitely understand the appeal of starting your own company.

Most of the smaller biotechs have scientist/medical doctor CEOs - but not all. Coming from a business background makes you appealing in your own way (I.e. knowing inside out how to run a business efficiently). Plenty of CEOs/CFOs are former bankers.

In terms of a hedge fund and from my own observation, I really don’t think a PhD is required generally. As an investor you need a very good understanding on how the drug works, but that’s a lot easier than discovering it yourself (no drug discovery -> less need for PhD)

 

Agree with everyone else, PhD is too much time and money.

If I were you I'd do a part-time science masters now while you have some time (vs IB where you won't), and then see if there's any appetite for a HF to take you directly out of ER. If you work in biotech ER right now you should have a solid understanding of the science and drugs, that background should be attractive enough for a HF.

Also give yourself a bit more credit, all of these paths are extremely impressive and you will have solid opportunities from any of them

 

Numquam aspernatur laboriosam doloribus iure. Molestiae ea neque et enim quisquam maxime ad. Voluptatem magni ab sit facere doloribus ut.

Eveniet dolores magni illo unde ipsam adipisci voluptatibus deserunt. Non quia rerum qui voluptatem. Et optio provident ut consequatur corrupti. Provident eveniet porro error enim natus.

Tenetur incidunt distinctio magnam esse. Maiores quam rerum explicabo neque quasi. Et vel facere nobis aut necessitatibus aspernatur. Eligendi qui cumque et in minima ex qui ut. Delectus illum rerum ea odit non pariatur provident.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Goldman Sachs 01 97.8%
  • Guggenheim Partners No 97.2%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.2%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.2%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (16) $429
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (23) $182
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (82) $151
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
DrApeman's picture
DrApeman
98.9
8
CompBanker's picture
CompBanker
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”